Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
13.96
-0.83 (-5.58%)
Mar 31, 2025, 9:43 AM EDT - Market open
Denali Therapeutics Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$37.57
Upside
+169.22%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +100.64% | Mar 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $41 → $33 | Buy | Initiates | $41 → $33 | +136.47% | Mar 7, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $38 → $35 | Strong Buy | Reiterates | $38 → $35 | +150.81% | Mar 5, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $50 → $42 | Buy | Maintains | $50 → $42 | +200.97% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $87 | Strong Buy | Maintains | $80 → $87 | +523.43% | Feb 28, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +122.14% | Feb 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $45 → $40 | Strong Buy | Maintains | $45 → $40 | +186.64% | Jan 28, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $28 → $24 | Buy | Maintains | $28 → $24 | +71.98% | Jan 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $90 → $87 | Strong Buy | Maintains | $90 → $87 | +523.43% | Jan 7, 2025 |
| Baird | Baird | Buy Initiates $31 | Buy | Initiates | $31 | +122.14% | Jan 7, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 3, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $37 | Hold → Strong Buy | Upgrades | $37 | +165.14% | Dec 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +544.93% | Nov 7, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $40 → $45 | Strong Buy | Maintains | $40 → $45 | +222.47% | Nov 1, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $29 → $28 | Buy | Maintains | $29 → $28 | +100.64% | Oct 11, 2024 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.